Jan Oscarsson
5PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 03, 2025
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities.Douglas P Loesch, Manik Garg, Dorota Matelska
|Jun 28, 2024
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku
|Jun 14, 2022
Design and Analysis of Studies Based on Hierarchical Composite Endpoints: Insights from the DARE-19 Trial.Samvel B Gasparyan, Joan Buenconsejo, Elaine K Kowalewski
|Feb 24, 2021
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study.Jonas Oldgren, Sanna Laurila, Axel Åkerblom
Pageof 1
Frequent Collaborators
2 joint publications
Jonas Oldgren
2 joint publications
Eleni Rebelos
2 joint publications
Ele Ferrannini
2 joint publications
Pirjo Nuutila
1 joint publications
Samvel B Gasparyan
1 joint publications
Joan Buenconsejo
1 joint publications
Elaine K Kowalewski
1 joint publications
Olof F Bengtsson
1 joint publications
Aino Latva-Rasku
1 joint publications
Jouni Tuisku
